X0206 3 2021-12-03 0 0001835567 Pear Therapeutics, Inc. PEAR 0001021944 Temasek Holdings (Private) Ltd 60B ORCHARD ROAD, #06-18 TOWER 2, THE ATRIUM@ORCHARD SINGAPORE U0 238891 SINGAPORE 0 0 1 0 0001673754 TLS Beta Pte. Ltd. 60B ORCHARD ROAD #06-18 TOWER 2, THE ATRIUM@ORCHARD SINGAPORE U0 238891 SINGAPORE 0 0 1 0 0001379349 Temasek Life Sciences Private Ltd 60B ORCHARD ROAD #06-18 TOWER 2, THE ATRIUM@ORCHARD SINGAPORE U0 238891 SINGAPORE 0 0 1 0 0001379348 Fullerton Management Pte Ltd 60B ORCHARD ROAD #06-18 TOWER 2, THE ATRIUM@ORCHARD SINGAPORE U0 238891 SINGAPORE 0 0 1 0 0001896264 Elbrus Investments Pte. Ltd. 60B ORCHARD ROAD #06-18 TOWER 2, THE ATRIUM@ORCHARD SINGAPORE U0 238891 SINGAPORE 0 0 1 0 Class A Common Stock 26803573 I See footnotes The securities reported herein consist of 24,903,573 shares of Class A Common Stock of Pear Therapeutics, Inc. (the "Company") directly held by TLS Beta Pte. Ltd and 1,900,000 shares of Class A Common Stock of the Company directly held by Elbrus Investments Pte. Ltd. Each of TLS Beta Pte. Ltd. and Elbrus Investments Pte. Ltd. is a direct wholly-owned subsidiary of Temasek Life Sciences Private Limited ("TLS"). TLS is a direct wholly-owned subsidiary of Fullerton Management Pte Ltd ("FMPL"), which in turn is a direct wholly-owned subsidiary of Temasek Holdings (Private) Limited. TLS, FMPL and Temasek Holdings (Private) Limited may therefore be deemed to have or share beneficial ownership of the securities held by each of TLS Beta Pte. Ltd. and Elbrus Investments Pte. Ltd. Each Reporting Owner disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. TLS Beta Pte. Ltd., By: /s/ Fidah Alsagoff, Authorised Signatory 2021-12-09 Temasek Life Sciences Private Limited, By: /s/ Lim Siew Lee Sherlyn, Director 2021-12-09 Fullerton Management Pte Ltd, By: /s/ Gregory Tan, Director 2021-12-09 Elbrus Investments Pte. Ltd., By: /s/ Fidah Alsagoff, Authorised Signatory 2021-12-09 Temasek Holdings (Private) Limited, By: /s/ Jason Norman Lee, Authorised Signatory 2021-12-09